Ten healthy male and 10 healthy female, “never-smoking” subjects (ages 21—50) participated in a 5-day environmental room study to determine if an acute exposure to a high level of fresh diluted sidestream smoke (FDSS) would alter pulmonary function. On Monday, Tuesday, Thursday and Friday, the twenty subjects sat in an environmental room for 7.33 hours and were exposed to fi ltered and humidified air. On Wednesday, the twenty subjects were exposed in an environmental room for 7.33 hours to an average respirable suspended particle (RSP) concentration of 179 micrograms per m3 of FDSS generated by machine smoking Kentucky 1R4F reference cigarettes. This level of FDSS is 3.3 times the 95th percentile concentration of workplace environmental tobacco smoke exposure levels previously measured in the US. FVC and FEV1 decreased approximately 1.6% (p < 0.05) in both males and females after exposure. Similarly, PEF decreased approximately 1.3% (p < 0.03) following exposure. The observed decrease in pulmonary function was consistent with a “stress” related norepinephrine-induce d alteration in blood flow leading to transient bronchoconstriction. Alternatively, a cholinergic refl ex due to activation of bronchopulmonar y C fibers may have also played a role in the transient bronchoconstriction. These small exposure-related decrements in pulmonary function were reversible.
American Thoracic Society ( 1987). Standardization of spirometry: 1987 update. Am Rev Respir Dis136: 1285—1298.
2.
Aviado DM (1990). Non-epidemiologic studies on pulmonary carcinogens in environmental tobacco smoke: A critique of the Environmental Protection Agency's designation for environmental tobacco smoke as a group A carcinogen . (Document submitted to EPA, September 25, 1990.)
3.
Baker RR, Proctor CJ (1990). The origins and properties of environmental tobacco smoke. Environ Int16(3): 231—246.
4.
Barnes PJ (1994). Respiratory Pharmacology. In Textbook of Respiratory Medicine, 2nd edition, Murray JF, Nadel JA (eds). W.B. Saunders Company, Philadelphia, PA, pp 251—284.
5.
Carey IM, Cook DG, Strachan DP (1999). The effects of environmental tobacco smoke exposure on lung function in a longitudinal study of British adults. Epidemiology10(3): 319—326.
6.
California Environmental Protection Agency ( 1997). Health effects of exposure to environmental tobacco smoke: cardiovascular health effects. Offi ce of Environmental Health Hazard Assessment, Sacramento, CA. 8, 1—74.
7.
Dinh-Xuan AT , Chaussain M., Regnard J., Lockart A. (1989). Pretreatment with an inhaled α1-adrenergic agonist, methoxamine, reduces exercise-induced asthma. Eur Respir J2: 409—414.
8.
Eatough D., Hansen L., Lewis E. (1990). The chemical characterization of environmental tobacco smoke. Environ Technol11: 1071—1085.
9.
EisnerMD, Smith AK, Blanc PD (1998). Bartenders' respiratory health after establishment of smoke-free bars and taverns. JAMA280(22): 1909—1914.
10.
Giannini D. , Paggiaro PL, Moscato G., Gherson G., Bacci E., Bancalari L., Dente FL, DiFranco A., Vagaggini B., Giuntini C. (1997). Comparison between peak expiratory fl ow and forced expiratory volume in one second (FEV1) during bronchoconstriction induced by different stimuli . J Asthma34(2): 105—111.
11.
Hong J., Rodger IW, Lee L. (1995). Cigarette smoke-induced bronchoconstriction: Cholinergic mechanisms, tachykinins, and cyclooxygenas e products. J Appl Physiol78(6): 2260—2266.
12.
Jenkins AR, Palausky A., Counts RW, Bayne CK, Dindal AB, Guerin MR (1996). Exposure to environmental tobacco smoke in sixteen cities in the United States as determined by personal breathing zone air sampling. JExpo Anal EnvironEpidemiol6: 473—502.
13.
Kobzick L. (1999). The lung. In: Robbins Pathologic Basis of Disease, 6th ed. Cotran RS, Kumar V, Collins T (eds). W.B. Saunders Company , Philadelphia, PA, pp 697—755.
14.
Mercelle R. (1996). α-Adrenergic bronchoconstriction in man. Arch Physiol Biochem104(7): 851—854.
15.
Morris AH, Kanner RE, CrapoRO, Gardner RM (1984). Clinical Pulmonary Function Testing: A Manual of Uniform Laboratory Procedures, 2nd ed. Intermountain Thoracic Society, Salt Lake City, UT .
16.
Nelson PR, Conrad FW, Kelly RJ (1998). Comparison of environmental tobacco smoke to aged and diluted sidestream smoke. J Aerosol Sci281— 282.
17.
Ogden MW, Heavner DL, Foster TL, Maiolo KC, Cash SL, Richardson JD, Martin P., Simmons PS, Conrad FW, Nelson PR (1996). Personal monitoring system for measuring environmental tobacco smoke exposure. Environ Technol17: 239—250.
18.
Ogden MW, Maiolo KC (1992). Comparative evaluation of diffusive and active sampling systems for determining airborne nicotine and 3-ethenylpyridine. Environ Sci Technol26: 1226—1234.
19.
Rennard SI, Daughton DM (1993). Smoking reduction and biological markers of response . Monaldi Arch Chest Dis48: 580—582.
20.
Ruppel GL (1991). Manual of Pulmonary Function Testing, 5th ed. Mosby Year Book, St. Louis, MO.
21.
Smith CJ, Bombick DW, McKarns SC, Morton MJ, Morgan WT, Doolittle DJ (1996). Environmenta l room human physiology study using fresh diluted sidestream cigarette smoke. Proceedings of the 1996 Coresta Congress, Yokahama, Japan, November 6: 18—36.
22.
Smith CJ, Bombick DW, Ryan BA, Morgan WT, Doolittle DJ (2000). Urinary mutagenicity in nonsmokers following exposure to fresh diluted sidestream cigarette smoke. Mutation Research470: 53— 70.
23.
Smith CJ, McKarns SC, Davis RA, Livingstone SD, Bombick BR, Avalos JT, Morgan WT, Doolittle DJ (1996). Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. Mutat. Res.361: 1—9.
24.
Spina D., Rigby PJ, Paterson JW, Goldie RG (1989). α-Adrenoceptor function and autoradiographic distribution in human asthmatic lung. Br J Pharmacol97: 701—708.
25.
US Environmental Protection Agency, Offi ce of Health and Environmental Assessment, Offi ce of Atmospheric and Indoor Air Programs (1990). Health effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children. External Review Draft, EPA 600/6-90/006A, May, 1990.
26.
VanVunakisH. , Gjika HB, Langone JJ (1987). Radioimmunoassay for nicotine and cotinine. In: Environmental Carcinogens Methods of Analysis and Exposure Measurement , Vol. 9, O'Neill IK, Brunnemann KD, Dodet B, Hoffman D (eds). WHO. International Agency for Research on Cancer, Lyon, pp 317—330.
27.
Witorsch P. (1998). Effects of environmental tobacco smoke exposure on pulmonary function and respiratory health in adults: Update 1997. Indoor Built Environ7: 4—17.
28.
Woolcock AJ (1994). Respiratory Pharmacology. In: Textbook of Respiratory Medicine2nd ed. Murray JF, Nadel JA (eds). W.B. Saunders Company, Philadelphia, PA, pp 1288—1330.
29.
Yoshie Y., Lizuka K., Nakazawa T. (1989). The inhibitory effect of a selective α2-adrenergic receptor antagonist on moderate-to severe-type asthma. J All Clin Immunol84: 747—752.
